CCG-203971 (Standard)

Overview

CCG-203971 (Standard) is the analytical standard of CCG-203971 ( HY-108361 ). This product is intended for research and analytical applications. CCG-203971 is a second-generation Rho/MRTF/SRF pathway inhibitor. CCG-203971 potently targets RhoA/C-activated SRE-luciferase (IC 50 =6.4 μM). CCG-203971 inhibits PC-3 cell migration with an IC 50 of 4.2 μM. Potential anti-metastasis Agent.

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Ras

Product Information

• Catalog No.: HY-108361R
• CAS No.: 1443437-74-8
• Molecular Formula: C23H21ClN2O3
• Molecular Weight: 408.88
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source